Original article
Low tumor interleukin-1β expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation study
S. Safia,
, J. Krzykallab, H. Hoffmanna, A. Bennerb, H. Bischoffc, M. Eichhornd, M. Kriegsmanne, I. Poschkef, F. Stögbauerg, L. Umanskyf,h, C. Moglerg, W. Weichertg, H. Winterd, P. Beckhovei,1, T. Muleyj,1
Corresponding author
seyer.safi@mri.tum.de
Corresponding author at: University Hospital Rechts der Isar Technical University of Munich, Ismaninger Strasse 22, 81675 Munich, Germany.
Corresponding author at: University Hospital Rechts der Isar Technical University of Munich, Ismaninger Strasse 22, 81675 Munich, Germany.
a Division of Thoracic Surgery, University Hospital rechts der Isar, Technical University of Munich, Munich, Germany
b Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany
c Department of Thoracic Oncology, Thoraxklinik, University of Heidelberg, Heidelberg, Germany
d Department of Thoracic Surgery, Thoraxklinik, Heidelberg University Hospital, Heidelberg, Germany
e Institute of Pathology, Heidelberg University, Heidelberg, Germany
f Immune Monitoring Unit, National Center for Tumor Diseases, Heidelberg, Germany
g Institute of Pathology, Technical University of Munich, Munich, Germany
h Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany
i Regensburg Center for Interventional Immunology, University of Regensburg, Regensburg, Germany
j Translational Research Unit, Thoraxklinik, Heidelberg University Hospital, Heidelberg, Germany
Ver más
